Comera Investor Presentation Deck

Biologics Market is Massive and Growing Rapidly Global biologics market valued at $383B in 2022 and is expected to grow at an 8.8% CAGR through 20321 7 of the top 10 global medicines are biologics² Products across all major therapeutic indications Significant market opportunity for formulation improvements mAb therapies at the vanguard of cutting-edge biomedical technology and driving the next generation of treatments Outnumbering-Small-Molecule-Drugs.html Multiple $Billion Products Rituxan® Rituximab Herceptin trastuzumab SOLIRISⓇ (eculizumab) ( 1. Source: https://www.globenewswire.com/news-release/2022/08/09/2494541/0/en/The-Global-Biologics-market-is-projected-to-grow-at-a-CAGR-of-8-82-By-2032-Visiongain-Reports-Ltd.html 2. Source: https://www.globenewswire.com/news-release/2019/01/11/1690388/0/en/Global-Biologics-Outsourcing-Market-2018-2027-In-2017-7-out-of-10-Blockbuster-Drugs-were-Biologics- Remicade Comera LIFE SCIENCES INFLIXIMAB AVASTIN® bevacizumab OPDIVO (nivolumab) KEYTRUDA (pembrolizumab) TM 10

View entire presentation